Unstable Angina

• EMA approval · 2026-08-18
  EMA Authorised: Arixtra (fondaparinux sodium) — Viatris Healthcare Limited

  The EMA authorised Arixtra (fondaparinux sodium) for venous thrombosis, pulmonary embolism, myocardial infarction, and unstable angina, unde…

• EMA approval · 2026-01-29
  EMA Authorised: Arixtra (fondaparinux sodium) — Viatris Healthcare Limited

  The EMA authorised Arixtra (fondaparinux sodium) by Viatris Healthcare Limited for thromboembolic conditions including venous thrombosis, pu…

• EMA approval · 2025-11-13
  EMA Authorised: Efient (prasugrel) — Substipharm

  The EMA has authorised Efient (prasugrel) by Substipharm for indications including acute coronary syndrome, unstable angina, and myocardial …

• EMA approval · 2025-09-26
  EMA Authorised: Prasugrel Viatris (previously Prasugrel Mylan) (prasugrel besilate) — Viatris Limited

  EMA authorised Prasugrel Viatris (prasugrel besilate) by Viatris Limited; the product is approved for myocardial infarction, acute coronary …

• FDA approval · 2024-10-24
  FDA Approved: HEPARIN SODIUM — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

  FDA approved Pfizer's supplemental application for Heparin Sodium, the anticoagulant. The approval updates the product's labeling/indication…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2022-06-14
  FDA Approved: ENOXAPARIN SODIUM — Original Application (BluePoint Laboratories)

  The FDA approved BluePoint Laboratories' original ANDA for enoxaparin sodium, a low molecular weight heparin, expanding availability of its …

• EMA approval · 2022-03-17
  EMA Authorised: Integrilin (eptifibatide) — GlaxoSmithKline Trading Services Limited

  Authorised by EMA: Integrilin (eptifibatide) approved for unstable angina and myocardial infarction.

• FDA approval · 2020-07-17
  FDA Approved: CLOPIDOGREL — Original Application (POLYGEN PHARMACEUTICALS INC.)

  FDA approves Polygen Pharmaceuticals' original ANDA for a generic clopidogrel product.

• FDA approval · 2019-09-23
  FDA Approved: BIVALIRUDIN — Supplemental Application (Mylan Institutional LLC)

  FDA approved a supplemental application for Bivalirudin submitted by Mylan Institutional LLC.

• FDA approval · 2019-05-16
  FDA Approved: AGGRASTAT — Supplemental Application (Medicure International Inc)

  The FDA approved a supplemental application for AGGRASTAT (tirofiban) submitted by Medicure International Inc.

• FDA approval · 2018-09-04
  FDA Approved: TICAGRELOR — Original Application (Teva Pharmaceuticals, Inc.)

  FDA approves Teva's generic ticagrelor (ANDA 208390) as an original application approval for TICAGRELOR.

• FDA approval · 2016-07-12
  FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)

  The FDA has approved a supplemental application for Effient (prasugrel hydrochloride) submitted by Cosette Pharmaceuticals, Inc. This action…

• FDA approval · 2016-06-16
  FDA Approved: AGGRASTAT — Supplemental Application (Medicure International Inc)

  FDA approved a supplemental application for AGGRASTAT (tirofiban) submitted by Medicure International Inc. The action updates the drug's lab…

• FDA approval · 2015-07-07
  FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for EFFIENT (prasugrel hydrochloride) submitted by Cosette Pharmaceuticals, Inc.

• FDA approval · 2014-06-23
  FDA Approved: ENOXAPARIN SODIUM — Original Application (Italfarmaco SpA)

  FDA approved the original application for ENOXAPARIN SODIUM (enoxaparin sodium) submitted by Italfarmaco SpA under an ANDA. The approval con…

• FDA approval · 2013-10-30
  FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)

  The FDA approved a supplemental application for BRILINTA (ticagrelor) submitted by AstraZeneca Pharmaceuticals LP.

• FDA approval · 2013-04-04
  FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)

  The FDA approved a supplemental application for clopidogrel bisulfate submitted by Dr. Reddy's Laboratories Inc, for their generic clopidogr…

• FDA approval · 2013-03-05
  FDA Approved: AGGRASTAT — Supplemental Application (Medicure International Inc)

  FDA approved a supplemental application for AGGRASTAT (tirofiban) submitted by Medicure International Inc, indicating an update to the drug'…

• FDA approval · 2012-12-05
  FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)

  FDA approved a supplemental application for Brilinta (ticagrelor) from AstraZeneca Pharmaceuticals LP. This action approves changes to Brili…

• FDA approval · 2012-04-18
  FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)

  FDA approval of a supplemental application for clopidogrel bisulfate submitted by Dr. Reddy's Laboratories Limited.

• FDA approval · 2010-12-06
  FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)

  FDA approved Cosette Pharmaceuticals' supplemental application for EFFIENT (prasugrel hydrochloride).